SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TGEN - Targeted Genetics Corporation
TGEN 9.760-1.3%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike McFarland who wrote (524)3/29/2008 6:04:00 PM
From: Mike McFarlandRead Replies (1) of 557
 
The archived call is elevator music for about the first half,
so forward ahead. I didn't put together much in the way of
notes:

Meetings for arthritis data are:
asgt may
eular june
nov

next trial will be later this year or early next

Celladon data (heart failure) will be second half of 08

some results for the blindness trial first half 08
(I might not have got that right, maybe I meant 09?)

q&a
A R&R fellow asked about the Huntington's disease,
things here sounded promising--maybe TGEN's AAV is
working out pretty well there?
Reminded me of Ceregene.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News